Reimagining Vaccine Access for Health Equity.

Abstract

The Covid-19 pandemic elevated global attention to the complex problem of allocating and disseminating newly approved vaccines. Following early calls for vaccine equity,¹ global health leaders made progress but struggled to fully realize distribution goals.² With respect to vaccination rates, low and middle income countries have not achieved full parity with high income countries.³ In this issue, Harmon, Kholina, and Graham follow longstanding critiques of market-based vaccine procurement to propose "legal and practical solutions for realizing a new access to vaccines environment"⁴ that will, they suggest, further the goal of global health justice.